FGF9 and neoplasm: Seven days after tumor inoculation, mice were randomly assigned to receive the intratumoral (i.t.)injection of 5 ng FGF9, BSA (the vehicle control for FGF9) or no treatment (Control), and intraperitoneal (i.p.)injection of 20 mg/kg cordycepin or PBS (the vehicle control for cordycepin).